$AUR

Aurora Innovation, Inc.

CIK:0001828108|SEC Filings

Condensed Consolidated Statements of Operations (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 2	$ 1	$ 3	$ 1
Cost of revenue	7	5	13	5
Research and development	211	190	406	372
Selling, general and administrative	50	36	94	65
Loss from operations	(266)	(230)	(510)	(441)
Other income (expense):
Change in fair value of derivative liabilities	(16)	16	(17)	7
Other income, net	12	13	34	25
Loss before income taxes	(270)	(201)	(493)	(409)
Income tax expense	0	0	0	0
Net loss	$ (270)	$ (201)	$ (493)	$ (409)
Basic net loss per share (in usd per share)	$ (0.14)	$ (0.11)	$ (0.25)	$ (0.23)
Diluted net loss per share (in usd per share)	$ (0.14)	$ (0.11)	$ (0.25)	$ (0.23)
Basic weighted-average shares outstanding (in shares)	1,976	1,785	1,962	1,764
Diluted weighted-average shares outstanding (in shares)	1,976	1,785	1,962	1,764

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net loss	$ (493)	$ (409)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	12	11
Reduction in the carrying amount of right-of-use assets	13	14
Stock-based compensation	106	89
Change in fair value of derivative liabilities	17	(7)
Accretion of discount on investments	(1)	(8)
Other operating activities	(9)	0
Changes in operating assets and liabilities:
Other current and non-current assets	(2)	0
Operating lease liabilities	(13)	(14)
Other current and non-current liabilities	(14)	38
Net cash used in operating activities	(384)	(286)
Cash flows from investing activities
Purchases of property and equipment	(56)	(15)
Purchases of investments	(474)	(734)
Maturities and sales of investments	630	650
Net cash provided by (used in) investing activities	100	(99)
Cash flows from financing activities
Proceeds from issuance of common stock	247	427
Payments for taxes on net settlement of equity incentive awards	(44)	(45)
Other financing activities	0	(2)
Net cash provided by financing activities	203	380
Net decrease in cash, cash equivalents, and restricted cash	(81)	(5)
Cash, cash equivalents, and restricted cash at beginning of the period	235	227
Cash, cash equivalents, and restricted cash at end of the period	$ 154	$ 222

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 136	$ 221
Short-term investments	1,081	1,055
Other current assets	35	41
Total current assets	1,252	1,317
Property and equipment, net	164	103
Operating lease right-of-use assets	84	85
Acquisition related intangible assets, net	617	617
Long-term investments	0	183
Other assets	50	38
Total assets	2,167	2,343
Current liabilities:
Operating lease liabilities, current	12	11
Other current liabilities	98	100
Total current liabilities	110	111
Operating lease liabilities, long-term	70	73
Derivative liabilities, long-term	30	15
Other liabilities	4	4
Total liabilities	214	203
Commitments and contingencies
Stockholders’ equity:
Common stock - $0.00001 par value, 51,000 shares authorized, 1,998 and 1,943 shares issued and outstanding, respectively	0	0
Additional paid-in capital	7,621	7,312
Accumulated other comprehensive (loss) income	(1)	2
Accumulated deficit	(5,667)	(5,174)
Total stockholders’ equity	1,953	2,140
Total liabilities and stockholders’ equity	$ 2,167	$ 2,343